Ryan Specialty Holdings Inc. $RYAN Position Raised by Federated Hermes Inc.

Federated Hermes Inc. grew its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) by 36.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 733,446 shares of the company’s stock after acquiring an additional 197,594 shares during the quarter. Federated Hermes Inc. owned about 0.28% of Ryan Specialty worth $49,867,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. lifted its position in Ryan Specialty by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 10,271,428 shares of the company’s stock valued at $758,750,000 after purchasing an additional 390,924 shares during the last quarter. Montrusco Bolton Investments Inc. acquired a new stake in shares of Ryan Specialty in the second quarter valued at approximately $213,852,000. Blair William & Co. IL raised its holdings in shares of Ryan Specialty by 1.1% during the second quarter. Blair William & Co. IL now owns 2,814,195 shares of the company’s stock valued at $191,337,000 after buying an additional 29,279 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Ryan Specialty by 0.5% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,378,573 shares of the company’s stock valued at $175,706,000 after buying an additional 12,573 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Ryan Specialty by 3.9% during the second quarter. Geode Capital Management LLC now owns 2,018,275 shares of the company’s stock worth $137,244,000 after buying an additional 75,598 shares during the period. Institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

RYAN has been the topic of several analyst reports. Wolfe Research upgraded Ryan Specialty to a “strong-buy” rating in a research report on Tuesday, September 16th. Keefe, Bruyette & Woods decreased their price target on Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. UBS Group lowered their price target on Ryan Specialty from $80.00 to $75.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their target price on shares of Ryan Specialty from $64.00 to $63.00 and set an “underweight” rating for the company in a research report on Thursday, October 9th. Finally, Barclays lowered their target price on shares of Ryan Specialty from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Thursday, November 20th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $66.60.

Read Our Latest Stock Report on RYAN

Insider Buying and Selling

In other Ryan Specialty news, Chairman Patrick G. Ryan bought 276,634 shares of Ryan Specialty stock in a transaction that occurred on Friday, September 12th. The stock was purchased at an average cost of $51.84 per share, for a total transaction of $14,340,706.56. Following the completion of the acquisition, the chairman owned 13,699,959 shares of the company’s stock, valued at approximately $710,205,874.56. This represents a 2.06% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 52.21% of the stock is currently owned by corporate insiders.

Ryan Specialty Trading Down 2.3%

Shares of RYAN stock opened at $53.86 on Tuesday. The stock has a 50-day simple moving average of $55.63 and a 200 day simple moving average of $59.70. Ryan Specialty Holdings Inc. has a fifty-two week low of $50.08 and a fifty-two week high of $77.16. The stock has a market capitalization of $14.21 billion, a P/E ratio of 117.08, a P/E/G ratio of 1.54 and a beta of 0.61. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 2.72.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.47 EPS for the quarter, hitting the consensus estimate of $0.47. Ryan Specialty had a net margin of 7.61% and a return on equity of 47.93%. The firm had revenue of $754.58 million for the quarter, compared to analysts’ expectations of $742.35 million. During the same period in the previous year, the business earned $0.41 earnings per share. Ryan Specialty’s revenue for the quarter was up 24.8% compared to the same quarter last year. On average, sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Tuesday, November 11th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Monday, November 10th. Ryan Specialty’s payout ratio is presently 104.35%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.